Men and women who are 18+, with schizophrenia or schizoaffective disorder, are invited to be involved in an adjunctive treatment study that is underway in Melbourne. Hormones are known to play a role in the expression of schizophrenia and related disorders. The Monash Alfred Psychiatry research centre is investigating whether a treatment that targets hormones, when taken in combination with regular antipsychotic medication, can better improve psychotic symptoms, mood and cognitive functioning. Participants will be reimbursed for their time and travel can be negotiated. See more: Link
We have created an index page which lists research studies being undertaken by various Departments within Central Clinical School which are seeking participants. You can login with your Monash authcate and add your own study. We get an email to prompt the publication of the entry and disseminate it more widely.
Participants sought: Medication in smoking cessation
MAPrc study will examine important safety aspects (such as agitation, aggression and depression) of the drugs varenicline and bupropion compared to placebo (“dummy pills” that do not contain any medicine) and nicotine-replacement therapy (NRT or “the patch”) in smokers with or without a history of being diagnosed with a psychiatric disorder. See more: Link
Adding your study to CCS's research study index page
|Image: Debbra Sweet|
Studies are investigating a wide range of diseases, including allergies, Irritable Bowel Syndrome and gluten intolerance, schizophrenia and depression. The studies may seek both well and unwell participants. See index page which links to detail for each study currently seeking participants: Research study index link